Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | MPO | P05164 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7536240 | 0.84 | TLR8 (0.43) | MCL1 | |
| SCHEMBL30239860 | 0.82 | TAAR1 (0.39) | MCL1 | |
| SCHEMBL3818954 | 0.81 | TDP1 (0.33) | — | |
| SCHEMBL134471 | 0.79 | CYP1A2 (0.48) | SIGMAR1MTNR1AMCL1GPR84SLC6A4 | |
| SCHEMBL5159102 | 0.78 | MEN1 (0.60) | MEN1KMT2AMTNR1AMCL1 | |
| SCHEMBL302931 | 0.78 | CYP1A2 (0.47) | SIGMAR1MTNR1AMCL1GPR84SLC6A4 | |
| SCHEMBL303705 | 0.78 | CYP1A2 (0.47) | SIGMAR1MTNR1AMCL1GPR84SLC6A4 | |
| SCHEMBL303785 | 0.78 | CYP1A2 (0.47) | SIGMAR1MTNR1AMCL1GPR84SLC6A4 | |
| SCHEMBL304711 | 0.78 | CYP1A2 (0.47) | SIGMAR1MTNR1AMCL1GPR84SLC6A4 | |
| SCHEMBL303608 | 0.78 | CYP1A2 (0.47) | SIGMAR1MTNR1AMCL1GPR84SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1114834-A | antidiabetic agent | OTSUKA PHARMA CO LTD (JP) | 1996-01-10 | — | — | CN | disclosed |